Oppenheimer Reiterates Outperform on Mindray Medical International

by Emily Austin, Benzinga Staff Writer

July 5, 2011 7:35 AM | 13 seconds read | Make a Comment

Oppenheimer reiterated its Outperform rating on Mindray Medical International

. At the moment, Oppenheimer has a price target of $32 placed on the company's stock. On Friday, Mindray added 4.35% to its value to finish the day at $29.27.

Market News and Data brought to you by Benzinga APIs

Posted In: Reiteration Analyst Ratings Health Care Health Care Equipment Mindray Medical Oppenheimer

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Oppenheimer Reiterates Outperform on Mindray Medical International